Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1–25 of 27,380 studies, newest first · page 1 of 1096.

November 2026 5

  1. 2026-11-01

    Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment

    ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment Research Square

    Key finding: Among 10,489 participants with incident MCI, the mean age at the incident MCI wave was 70.6 years (SD = 11.53), and 56.6% were female. +4 more findings

    Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-11-01

    Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology Research Square

    Key finding: Because alpha-synuclein pathology is associated with central and peripheral immune alterations, targeted measurement of inflammation-related biomarker candidates may provide a minimally invasive means of characterizing disease biology and supporting differential diagnosis. +3 more findings

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-11-01

    Molecular MRI of Neuroinflammation in Alzheimer's Disease using a Folate-targeted Nanoprobe

    ⚠ Preprint — not yet peer-reviewed Inflammation and the immune system bioRxiv

    Key finding: Microglial activation and FR expression in APP/PS1 and P301S transgenic mouse models of AD was measured using flow cytometry. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-11-01

    Large-scale head-to-head comparison of on- and off-target profiles of [18F]Tauvid and [18F]MK6240 tau-PET in aging and Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Research Square

    Key finding: [ 18 F]Tauvid and [ 18 F]MK6240 capture largely overlapping patterns of tau pathology, but differ notably in the magnitude of off-target binding. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-11-01

    Longitudinal plasma biomarkers and multimodal PET across APOE ε4 genotypes: a prospective cohort study

    ⚠ Preprint — not yet peer-reviewed Biomarkers Research Square

    Key finding: These findings support a model in which p-tau217 specifically tracks amyloid-driven pathological progression, while markers of neurodegeneration reflect broader age-related processes that are not associated with APOE genotype. +2 more findings

    Scored 42 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

October 2026 20

  1. 2026-10-31

    Repetitive negative thinking is associated with amyloid accumulation over 3 years in cognitively healthy adults

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging medRxiv

    Key finding: RNT was associated with increasing global amyloid accumulation even after controlling for psychological symptoms (B = 0.0120, 95% Confidence Interval 0.003 to 0.021, P = 0.012), and in sensitivity analyses limited to participants aged ≥50 or ≥60. +4 more findings

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-10-31

    APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model

    ⚠ Preprint — not yet peer-reviewed Genetics Research Square

    Key finding: Here, we employed an integrated transcriptomic and cellular approach to identify and validate biomarkers associated with AD pathology. +3 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-10-30

    Neuroinflammation is an early pathological process in a mouse model of prodromal Parkinsons disease

    ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment bioRxiv

    Key finding: Stereological quantification revealed no significant neuronal loss in the AON or PCX during this 1–3 month interval, indicating that olfactory impairment precedes overt neurodegeneration. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-10-30

    TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology bioRxiv

    Key finding: We demonstrated that TMEM CT neuronal aggregation drives severe neuronal dysfunction and neuronal loss. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-10-30

    Opposing Regulation of Tau Condensation by Phosphorylation Levels and Molecular Chaperone Interactions

    ⚠ Preprint — not yet peer-reviewed Treatments bioRxiv

    Key finding: We found that the phosphorylation pattern modulates Tau fibrillation and enhances its droplet-formation propensity. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-10-30

    Tau-CTFP: A connectome-informed continuous-time first-passage model for forecasting the onset of regional tau PET abnormality

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: Tau PET burden is associated with subsequent cognitive decline in Alzheimer's disease, motivating forecasts for monitoring and studies of spatially targeted therapies. +2 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2026-10-30

    Integrative systems biology identifies shared neuroimmune co-expression programmes across pulmonary tuberculosis and Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed Genetics Research Square

    Key finding: Active PTB was associated with widespread transcriptional remodeling, with 1,389 dysregulated genes organized into 16 PTB-associated co-expression modules. +4 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-10-30

    Disrupting SORL1-retromer endosomal recycling in mice drives the age-dependent neurodegenerative signature of Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv

    Key finding: MRI studies revealed that SORL1 deficiency induced an age-dependent AD-pattern of atrophy, centered on the trans-entorhinal cortex, and that atrophy was prevented by SORL1 restoration, secondary to overexpressing the retromer protein VPS26b. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-10-30

    Pregnancy History and Loss of Normal PSEN2 Function Impact Female Late-Life Cognitive Processing, Inhibitory Signaling, and Gliosis

    ⚠ Preprint — not yet peer-reviewed Risk genes beyond APOE bioRxiv

    Key finding: This work suggests that although parity history and PSEN2 deficiency exert individual differing age-related effects on cognition and neurobiology, they do not act synergistically.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-10-30

    The Alzheimer's disease-associated rs28834970 variant in PTK2B impairs electrical activity and regulates Tau phosphorylation and APP processing in human neuronal cultures

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv

    Key finding: The rs28834970 regulatory variant was identified as the most functionally relevant in our model, with the C risk allele promoting transcription factor C/EBPβ binding within a cis-regulatory element. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2026-10-30

    Concurrent cognitive, behavioral and systemic physiological features mark preclinical Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv

    Key finding: Reported modifiable risk factor histories were not associated with p-tau217 when effectively managed. +1 more finding

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  12. 2026-10-30

    The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration

    ✓ Peer-reviewed Drug development Metabolism: clinical and experimental

    Key finding: Converging epidemiological, mechanistic, and pharmacological evidence supports a bidirectional metabolic-brain axis in which systemic insulin resistance, obesity, and chronic metabolic inflammation are associated with and may contribute to alterations in neuronal survival, synaptic plasticity, and neuroimmune homeostasis. +2 more findings

  13. 2026-10-30

    Differential endothelial cell remodeling in Down syndrome and APP duplication drives distinct blood brain barrier dysfunction

    ⚠ Preprint — not yet peer-reviewed Down syndrome and Alzheimer's bioRxiv

    Key finding: However, we reported greater vascular Aβ deposition in APPdup than in DS with AD, suggesting that other triplicated chromosome 21 genes may mitigate CAA severity. +2 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-10-29

    Elder Caregiving in Southeast Asia: A Systematic Review of Cultural Norms, Care Burdens, Carer Support and Policy Gaps

    ⚠ Preprint — not yet peer-reviewed Caregiving Research Square

    Key finding: Forty-eight studies from ten Southeast Asian countries were reviewed. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2026-10-29

    Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research Square

    Key finding: Aβ42 oligomer adsorption increases cellular Young's modulus, which is associated with sustained intracellular Ca 2+ elevation mediated by Piezo1. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-10-29

    Evaluating a primary care pharmacist-led intervention to reduce opioid use for persistent non-cancer pain: the PROMPPT cluster randomised controlled trial protocol

    ✓ Peer-reviewed Clinical trials NIHR Open Res

    Key finding: The PROMPPT trial will assess whether review by trained clinical pharmacists working in general practices can support safe opioid reduction without compromising pain management and quality of life. +1 more finding

  17. 2026-10-29

    Effect of Metformin on tau pathology and proteostasis in cellular and a Drosophila model of Tauopathy

    ⚠ Preprint — not yet peer-reviewed Drug development Research Square

    Key finding: This dissociation was associated with enhanced activation of AKT and AMPK signalling and maintenance of basal phosphatase activity. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-10-29

    Endocannabinnoids innervate Circadian mechinary mitigating neuroinflammation, amyloidogenesis and cognition phenotypic to AD

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Authorea Preprints

    Key finding: Constant LL exposure induced complete arrhythmicity and impaired recognition, working, and spatial reference memory. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-10-29

    A Wasserstein Weisfeiler-Lehman Kernel Framework for Multimodal Brain Connectome Analysis

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Research Square

    Key finding: Under nested cross-validation, the WWL kernel achieves a balanced accuracy of $0.651\pm0.028$, significantly outperforming both a raw-feature SVM and a histogram-based WL-kernel baseline. +2 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  20. 2026-10-29

    PIN1-p53 bifurcation dictates opposite cell fate decisions in Alzheimer’s disease and glioblastoma via distinct energy landscape topologies

    ⚠ Preprint — not yet peer-reviewed Genetics Research Square

    Key finding: Although Alzheimer’s disease (AD) and glioblastoma (GBM) share common aging-related risk factors, they lead to opposite cellular fates—neurodegeneration versus uncontrolled proliferation. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →